DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Butylphthalide is an investigational drug.
There have been 13 clinical trials for Butylphthalide. The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2015.
The most common disease conditions in clinical trials are Stroke, Ischemia, and Cerebral Infarction. The leading clinical trial sponsors are CSPC-NBP Pharmaceutical Co., Ltd., Peking Union Medical College Hospital, and The Second Hospital of Hebei Medical University.
Recent Clinical Trials for Butylphthalide
|Study of Collateral Circulation in Patients With Symptomatic Intracranial Anterior Circulation Occlusion||The Second Hospital of Hebei Medical University||Phase 4|
|Efficacy and Safety of Butylphthalide Soft Capsule for the Treatment of Vascular Dementia||CSPC-NBP Pharmaceutical Co., Ltd.||Phase 3|
|Efficacy and Safety of Butylphthalide Soft Capsule for the Treatment of Vascular Dementia||Capital Medical University||Phase 3|